|

ADC THERAPEUTICS SA (ADCT)

CH0499880968 - Common Stock

1.02  -0.05 (-4.67%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
122.56M209.90M33.90M0.002.30M
Cost Of Goods
2.02M2.10M1.40MN/AN/A
Gross Profit
120.55M207.80M32.50MN/AN/A
Operating Expenses
258.34M328.70M302.30M219.30M121.70M
Research and Development
146.67M185.90M164.00M140.30M106.30M
Selling, General, and Administrative Expenses
128.09M140.60M135.80M93.00M13.80M
Operating Income
-137.79M-120.90M-269.80M-219.30M-119.40M
Interest Income/Expense
-42.90M8.00M10.00M-25.70M1.80M
Other Income/Expense
-117.00K400.00K200.00K-1.00M1.70M
Non Recurring Items
N/A-42.10M8.10MN/A0.00
Income Before Taxes
-181.50M-154.70M-251.50M-246.00M-115.90M
Income Tax
-2.99M1.10M-21.50M300.00K600.00K
Net Income
-178.52M-155.80M-230.00M-246.30M-116.50M
EBITDA
-134.96M-118.57M-267.17M-217.15M-117.75M
 
Per Share Data
EPS Diluted Total Ops
-2.20-1.99-3.00-3.21-1.52
Non GAAP EPS
-2.20-2.01-2.80N/AN/A
 
Statistics
Gross Profit Margin
98.36%99.00%95.87%N/AN/A
Profit Margin
-145.65%-74.23%-678.47%N/A-5065.22%
Operating Profit Margin
-112.43%-57.60%-795.87%N/A-5191.30%

All data in USD

Charts